Cargando…

COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study

Background: COVID-19 is responsible for increasing deaths globally. As most people dying with COVID-19 are older with underlying long-term conditions (LTCs), some speculate that YLL are low. We aim to estimate YLL attributable to COVID-19, before and after adjustment for number/type of LTCs, using t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanlon, Peter, Chadwick, Fergus, Shah, Anoop, Wood, Rachael, Minton, Jon, McCartney, Gerry, Fischbacher, Colin, Mair, Frances S., Husmeier, Dirk, Matthiopoulos, Jason, McAllister, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927210/ https://www.ncbi.nlm.nih.gov/pubmed/33709037 http://dx.doi.org/10.12688/wellcomeopenres.15849.3

Ejemplares similares

Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019)

Analysis of age–sex and deprivation stratified trends in assault deaths in Scotland (1974–2015) to identify age, period or cohort effects
por: Parkinson, Jane, et al.
Publicado: (2020)

Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974–2015?
por: Parkinson, Jane, et al.
Publicado: (2020)

Trends in infant mortality and stillbirth rates in Scotland by socio-economic position, 2000–2018: a longitudinal ecological study
por: Harpur, Alice, et al.
Publicado: (2021)

Recent adverse mortality trends in Scotland: comparison with other high-income countries
por: Fenton, Lynda, et al.
Publicado: (2019)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

How have changes in death by cause and age group contributed to the recent stalling of life expectancy gains in Scotland? Comparative decomposition analysis of mortality data, 2000–2002 to 2015–2017
por: Ramsay, Julie, et al.
Publicado: (2020)

Margaret McCartney: Glasgow’s lost hospital beds
por: McCartney, Margaret
Publicado: (2016)

Socioeconomic inequality in recent adverse all-cause mortality trends in Scotland
por: Fenton, Lynda, et al.
Publicado: (2019)

Is austerity responsible for the recent change in mortality trends across high-income nations? A protocol for an observational study
por: McCartney, Gerry, et al.
Publicado: (2020)

Informing Investment to Reduce Inequalities: A Modelling Approach
por: McAuley, Andrew, et al.
Publicado: (2016)

Recent cohort effects in suicide in Scotland: a legacy of the 1980s?
por: Parkinson, Jane, et al.
Publicado: (2017)

Drug-related deaths in Scotland 1979–2013: evidence of a vulnerable cohort of young men living in deprived areas
por: Parkinson, Jane, et al.
Publicado: (2018)

How bad are life expectancy trends across the UK, and what would it take to get back to previous trends?
por: Minton, Jon, et al.
Publicado: (2020)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

Changing mortality trends in countries and cities of the UK: a population-based trend analysis
por: Walsh, David, et al.
Publicado: (2020)

Deaths from ‘diseases of despair’ in Britain: comparing suicide, alcohol-related and drug-related mortality for birth cohorts in Scotland, England and Wales, and selected cities
por: Walsh, David, et al.
Publicado: (2021)

Visualising and quantifying ‘excess deaths’ in Scotland compared with the rest of the UK and the rest of Western Europe
por: Minton, Jon, et al.
Publicado: (2017)

Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
por: Crowther, Jamie, et al.
Publicado: (2023)

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
por: Sullivan, Michael K., et al.
Publicado: (2021)

Can changes in spending on health and social care explain the recent mortality trends in Scotland? A protocol for an observational study
por: Wraw, Christina, et al.
Publicado: (2020)

Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people
por: Hanlon, Peter, et al.
Publicado: (2021)

Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023)

Two cheers for a small giant? Why we need better ways of seeing data: A commentary on: ‘Rising morbidity and mortality in midlife among White non-Hispanic Americans in the 21st century’
por: Minton, Jonathan, et al.
Publicado: (2017)

Enhanced detection services for developmental dysplasia of the hip in Scottish children, 1997–2013
por: McAllister, David, A, et al.
Publicado: (2018)

How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland
por: Wyper, Grant M. A., et al.
Publicado: (2020)

Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)

Human Tissue-Resident Memory T Cells in the Maternal–Fetal Interface. Lost Soldiers or Special Forces?
por: DeJong, Caitlin S., et al.
Publicado: (2020)

Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020)

Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
por: Wightman, Heather, et al.
Publicado: (2023)

Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2020)

Does ethnic diversity explain intra-UK variation in mortality? A longitudinal cohort study
por: Schofield, Lauren, et al.
Publicado: (2019)

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022)

Prevalence, measurement, and implications of frailty in stroke survivors: An analysis of three global aging cohorts
por: Hanlon, Peter, et al.
Publicado: (2023)

Frailty in people with rheumatoid arthritis: a systematic review of observational studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Population health post-pandemic: critiquing the economic approach to recovery
por: Shipton, Debs, et al.
Publicado: (2021)

How can socioeconomic inequalities in hospital admissions be explained? A cohort study
por: McCartney, Gerry, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_32k6igi0ufc917e2na4ikcmetu